- Home
- NARI vs FHI Comparison
NARI vs FHI Comparison
Compare NARI & FHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NARI
- FHI
- Stock Information
- Founded
- NARI 2011
- FHI 1955
- Country
- NARI United States
- FHI United States
- Employees
- NARI N/A
- FHI N/A
- Industry
- NARI Medical/Dental Instruments
- FHI Investment Managers
- Sector
- NARI Health Care
- FHI Finance
- Exchange
- NARI Nasdaq
- FHI Nasdaq
- Market Cap
- NARI 3.0B
- FHI 3.1B
- IPO Year
- NARI 2020
- FHI N/A
- Fundamental
- Price
- NARI $49.66
- FHI $42.32
- Analyst Decision
- NARI Buy
- FHI Buy
- Analyst Count
- NARI 10
- FHI 6
- Target Price
- NARI $59.13
- FHI $43.33
- AVG Volume (30 Days)
- NARI 918.3K
- FHI 670.2K
- Earning Date
- NARI 10-28-2024
- FHI 10-24-2024
- Dividend Yield
- NARI N/A
- FHI 2.93%
- EPS Growth
- NARI N/A
- FHI 3.08
- EPS
- NARI N/A
- FHI 3.16
- Revenue
- NARI $574,498,000.00
- FHI $1,598,907,000.00
- Revenue This Year
- NARI $24.59
- FHI $2.01
- Revenue Next Year
- NARI $18.28
- FHI $6.58
- P/E Ratio
- NARI N/A
- FHI $13.38
- Revenue Growth
- NARI 22.41
- FHI 0.44
- 52 Week Low
- NARI $36.73
- FHI $31.08
- 52 Week High
- NARI $67.13
- FHI $42.56
- Technical
- Relative Strength Index (RSI)
- NARI 53.46
- FHI 66.30
- Support Level
- NARI $47.96
- FHI $40.81
- Resistance Level
- NARI $52.59
- FHI $42.48
- Average True Range (ATR)
- NARI 2.13
- FHI 0.70
- MACD
- NARI -0.36
- FHI -0.11
- Stochastic Oscillator
- NARI 29.77
- FHI 91.46
About NARI Inari Medical Inc.
Inari Medical Inc is a medical device company focused on developing products to treat patients suffering from Chronic Venous Disease. Its product portfolio includes; ClotTriever, for the removal of the clot from peripheral blood vessels and treats patients suffering from deep vein thrombosis. The FlowTriever System product is used for the treatment of pulmonary embolism, InThrill system to treat small vessel thrombosis, LimFlow system and others. Geographically, the company generates majority of its revenue from United States and rest from International markets.
About FHI Federated Hermes Inc.
ederated provides asset management services for institutional and individual investors. The company had $757.6 billion in managed assets at the end of December 2023, composed of equity (10%), multi-asset (less than 1%), fixed-income (13%), alternative (3%), and money market (74%) funds. That said, the firm's cash-management operations are expected to generate around 46% of Federated's revenue this year, compared with 29%, 13%, and 11%, respectively, for the firm's equity, fixed-income, and alternatives/multi-asset operations. From a channel perspective, the company's products are distributed via trust banks, wealth managers and retail broker/dealers (63% of AUM), institutional investors (28%), and international clients (9%).